Ginkgo Biloba EGb 761 Cognitive Meta-Analysis: Elderly Cognitive Decline Meaningfully Supported
WELLNESS

Ginkgo Biloba EGb 761 Cognitive Meta-Analysis: Elderly Cognitive Decline Meaningfully Supported

By Polly · · https://www.cochranelibrary.com/
KO | EN

Ginkgo is a living fossil that has survived on Earth for about 270 million years. The leaf extract EGb 761 showed meaningful adjunct effect for elderly cognitive decline patients in a 2025 meta-analysis.

Meta-analysis core results

Participants: Multiple RCTs aggregated. Mild cognitive impairment (MCI), early Alzheimer’s patients.

Dose: EGb 761 standardized extract 240 mg/day.

Duration: 22~24 weeks.

ADAS-cog score improvement: Meaningfully improved.

SKT score improvement: Cognitive function improvement.

Daily activity improvement: Mild effect.

Behavioral symptom reduction: Some data.

Side effects: Minimal. Favorable safety (bleeding risk caution).

Ginkgo and EGb 761

Ginkgo (Ginkgo biloba):

  • Living fossil. 270+ million years evolution
  • Native to East Asia (China, Korea, Japan)
  • Traditional medicinal use 1,000+ years

EGb 761:

  • Best-studied standardized extract
  • 50:1 concentration
  • Mainly clinical data this extract

Active matrix:

  • Flavonoids (quercetin, kaempferol, isorhamnetin): 24%
  • Terpenoids (bilobalide, ginkgolides A, B, C): 6%
  • Antioxidant synergy

General extract vs EGb 761:

  • EGb 761 has accurate standardization ratio
  • General extracts inconsistent
  • Large clinical effect difference

Mechanism

Microcirculation improvement:

  • Capillary strengthening
  • Brain microcirculation support
  • Limb microcirculation (peripheral)

Platelet-activating factor (PAF) inhibition:

  • Bilobalide, ginkgolides antagonize PAF
  • Coagulation dampening (bleeding risk concurrent)

Oxidative stress reduction:

  • Strong antioxidant
  • Neuroprotection

Mitochondrial protection:

  • Neuronal ATP

Neurotransmitter modulation:

  • Acetylcholine support
  • Some dopamine, serotonin

Inflammation reduction:

  • Some NF-κB inhibition

Multi-mechanism: Microcirculation + antioxidant + neuroprotection + neurotransmitter 4-axis.

Who should supplement

Mild cognitive impairment (MCI): After physician evaluation.

Early Alzheimer’s: Adjunct with drugs (physician evaluation).

Aging + cognitive concern: Option for 60+.

Peripheral microcirculation decline:

  • Cold limbs
  • Some varicose vein data

Tinnitus:

  • Some data

Eye microcirculation:

  • Some macular degeneration data

Who should be careful (important)

Anticoagulants (warfarin, aspirin, clopidogrel):

  • PAF inhibition compounds bleeding risk
  • Physician evaluation essential
  • Avoid major bleeding risk combinations

Antidepressants (SSRI):

  • Some drug concentration effects

Pre-surgery:

  • Discontinue 1~2 weeks prior (bleeding risk)

Pregnancy/breastfeeding: Limited data. Avoid.

Epilepsy:

  • Some reports
  • Physician evaluation

Allergy: Ginkgo allergy caution. Self or cross.

GI sensitivity: Some have GI discomfort.

Rare reports: Headache, dizziness.

Dose and forms

EGb 761 clinical standard: 120~240 mg/day.

Mild cognitive impairment: 240 mg/day.

General adjunct: 120 mg/day.

Duration: Effect assessment at 8~24 weeks. Chronic use general.

Timing: With meals. 1~2 times split.

Form comparison

EGb 761 (Tebonin, Tanakan etc.):

  • Clinical standard
  • Accurate standardization

Other standardized extracts:

  • 24% flavonoid + 6% terpenoid matching recommended

General ginkgo extracts:

  • Weak standardization
  • Effect inconsistent

General ginkgo (tea):

  • Dietary option
  • Weak effect

Combination forms:

  • Ginkgo + vitamin E
  • Ginkgo + B vitamins
  • Ginkgo + ginseng (adaptogen)

Other cognitive adjuncts

Vitamin B12 + folate (L14):

  • Homocysteine reduction
  • Cognitive foundation

Omega-3 EPA/DHA:

  • Brain phospholipids
  • Cognitive general

Phosphatidylserine:

  • Brain phospholipids

Acetyl-L-carnitine:

  • Mitochondria

Bacopa monnieri:

  • Indian adaptogen
  • Cognition

Lion’s Mane mushroom:

  • NGF support
  • Neural plasticity

Ginkgo + B12 + omega-3 = cognitive matrix.

Daily guide

Step 1 - Physician evaluation:

  • Cognitive function assessment
  • Drug review (bleeding risk drugs)

Step 2 - Foundation:

  • Exercise, social activity, cognitive activity
  • Mediterranean diet

Step 3 - Matrix first:

  • Vitamin B12, folate, omega-3 evaluation/supplementation

Step 4 - Ginkgo start:

  • EGb 761 120~240 mg/day

Step 5 - 8~24 week assessment:

  • Cognitive testing

Step 6 - Monitoring:

  • Bleeding symptoms, drug interactions

Ginkgo EGb 761 is the natural option for elderly cognitive support. On the dietary foundation. With bleeding risk drug physician evaluation.